Image

Assesment and Comparison of Osteoporosis Risk Factors After Stroke

Assesment and Comparison of Osteoporosis Risk Factors After Stroke

Recruiting
55-85 years
All
Phase N/A

Powered by AI

Overview

The aim of this study is to evaluate the effect of these factors and stroke itself on osteoporosis developing after stroke. Thus, the expected benefit of the study is to contribute to the identification and determination of the need for treatment in high-risk patients through further studies. There are no expected risks from the study.

Eligibility

Inclusion Criteria:

  1. Followed by ischemic or hemorrhagic stroke
  2. Between 1 week and 6 months or \>1 year has passed since the date of the event
  3. Being between 55 and 85 years of age

Exclusion Criteria:

  1. The patient has additional neurological conditions besides stroke
  2. The patient has a psychiatric condition
  3. History of recurrent stroke
  4. BMD scan performed within the last year for stroke patients
  5. Having received osteoporosis treatment before or after the stroke
  6. The patient having a fragility fracture before the stroke
  7. The patient having a hip fracture or hip prosthesis
  8. The patient having an additional condition that affects physical function before the stroke (amputation, severe fracture)
  9. The patient has an additional disease or medication use that could cause secondary osteoporosis
  10. The patient's stroke did not cause physical function loss

Study details
    Stroke Osteoporosis

NCT07228611

Ankara Etlik City Hospital

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.